Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. - Wikidata - wikimedia - TriplyDB

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

http://www.wikidata.org/entity/Q33723577

about

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future Resistance to β-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009-2013.Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology Extensive genomic variation within clonal complexes of Neisseria meningitidis.Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.Current epidemiology and growing resistance of gram-negative pathogens.In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?Plasmid-mediated resistance to tetracyclines among Neisseria gonorrhoeae strains isolated in Poland between 2012 and 2013.Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Is gonorrhea becoming untreatable?Gonococcal resistance: are cephalosporins next?Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing.In Vitro selection of Neisseria gonorrhoeae mutants with elevated MIC values and increased resistance to cephalosporins.Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China.Comparative proteomics analysis of Neisseria gonorrhoeae strains in response to extended-spectrum cephalosporins.Alanine 501 Mutations in Penicillin-Binding Protein 2 from Neisseria gonorrhoeae: Structure, Mechanism, and Effects on Cephalosporin Resistance and Biological Fitness.

P2860

Q24633203-4A6E3631-3F82-4276-9597-23DD00C4BD24 Q26796265-1619BEE5-B132-469C-9C78-4CE0181244A1 Q26862597-12536CD5-431B-4644-81AF-C542FEA8AA13 Q28080009-E010F134-4DC7-420C-BC5A-82511AB6A6FF Q30865577-E7BAAD61-CE3D-4086-9CDA-2E3E25C9DEEC Q33646692-D6588FB3-C495-4C75-BCED-69A895B640A4 Q34126619-8EBDEC6B-597A-4B23-97DB-1894379A69B8 Q34529041-452E4BFA-30F1-4AF8-A800-17F4FE5E78FC Q34563908-44141CD5-6E25-44FE-9AAA-692F09FB44BA Q34677116-48DFD88E-11B8-4881-84BF-551E93D1979F Q34916494-318C93B5-72C6-4311-997D-00EA692B96F8 Q35065794-843EFDE1-5100-40AB-9278-C4B26B91FF40 Q35087427-FF75BCC9-9E12-4020-8334-8D706F2FDEEC Q35090128-4C0DC564-67A5-4A6B-A95F-BDC9CA5F2C8E Q35623008-98519C92-A36C-4088-BA37-32A188C4CF85 Q35757713-3A8C1828-E034-4870-8FC1-1F4E25958F02 Q35806206-CDD7A860-5042-46D7-8943-E89E437B0838 Q35806407-9A4C0C8F-DB2A-4832-AB8D-1D0ED007810D Q35878450-05087396-AC3B-4766-89FE-C2D16E76177E Q35962785-0A33BB55-F05B-4591-8A0A-D7592227144D Q36025192-2C7A892A-5EB0-407E-873E-11CDA1A89231 Q36086360-2542315C-769D-4EE5-B8A3-8F12639CE4EE Q37531864-50C6FC95-5618-4C99-B3BC-7E6B9174CBAE Q37778640-4937EDD9-333E-4FBD-9996-F0F2B0B4A9F6 Q37844851-13AA7303-9EE2-4842-AA19-B38449B4E7EB Q37848735-3459482F-8AFD-4382-9D19-03EFC9CC1830 Q38652213-A2716CCE-5F84-47E7-BF04-F8BA8F462791 Q38654663-3BF16FC4-CA68-42E7-990C-A0F0104600FD Q39108153-C8E3B96F-87BE-46BC-8E5F-893EB6CEB36D Q40758663-EA78F6D8-9601-407F-83CA-F9DFE08A813E Q41748778-37C18F49-1D56-41D6-B620-AC63B659C72C Q42228002-6B79480D-BCA0-42E0-A793-A1395FD9CADA Q42228137-A13F729E-F93D-424E-9DD2-0D274572CA27 Q44024419-9BCE27F3-6B26-45CC-92EA-D89979650417 Q47095557-591C2BA8-BA77-457D-8DDD-E82C9F5C8986 Q48289899-46ACB09B-8E2F-4B5F-B6A8-CC9E0A330530

P2860

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.

http://www.wikidata.org/entity/Q33723577

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@ast

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@en

type

label

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@ast

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@en

prefLabel

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@ast

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@en

P1433

Q33723577-58A3B2C5-4644-4297-9B32-5F62F1A2983B

P1476

Q33723577-0126758F-6D47-43B2-ADB2-3016D41461D5

P2093

Q33723577-3CD54AC6-369E-4779-88A6-B3DFBA1BAD27

Q33723577-57107715-3BE1-4F21-917F-92CC36E61AB8

Q33723577-62836BA1-87EF-4F65-8C51-6FF636E1ED59

Q33723577-6C190665-1863-4D32-9170-9C422A89C848

Q33723577-74A88405-C0FE-48BD-83C5-10554C7C3E45

Q33723577-83C5AAA9-07D2-4656-9898-FA08AE07841F

Q33723577-D7EF6C94-3D70-4FC3-89A2-394DA9406CDD

Q33723577-FEDE65D0-050B-4172-9603-BFA29B48D088

P2860

Q33723577-0CB89125-3934-404A-8677-DFF33586D3AA

Q33723577-27EC9257-F6A4-4C73-963C-61140947479D

Q33723577-32132338-4840-43E5-96C6-C48DCF116379

Q33723577-3A325990-D656-46E9-9F76-03E81B009929

Q33723577-3BB1D705-905E-4C80-BAD2-9E6E0DD56AB8

Q33723577-44704290-2A46-4D31-AD12-7A7D8646EEE2

Q33723577-44E190FC-E448-4721-A643-2D35F2FF0DD8

Q33723577-468ADF99-0376-4F5F-A205-5087D7C9F727

Q33723577-4717536E-FD24-422E-A246-A365FD070E29

Q33723577-4AC3FEE0-FEBE-4335-A373-AAB8CF1388D3

P304

Q33723577-0BB52B38-CC47-42D3-B7E8-5327D2B7176C

P31

Q33723577-1F3326CD-536C-4AB7-8971-BC7BA4C4AB88

P356

Q33723577-27BFD1FC-E83C-40AC-BC22-FE26313EB0D1

P407

Q33723577-A61775B1-0FB1-4EFF-9905-AD0B869838F6

P433

Q33723577-94704DFF-463F-4FFA-94C9-F61A67BF2507

P478

Q33723577-36D7B312-ACBC-4024-862D-C1B13E317568

P577

Q33723577-BC90B27D-7F03-4EAF-9805-318DF192B2B9

P5875

Q33723577-DE8896CE-E77D-4C2D-A18A-6066800557CE

P698

Q33723577-B11A8684-DAFD-4145-A855-74ACC81659EC

P921

Q33723577-9E591D7F-87AF-4CC1-A073-614436BB05F4

P932

Q33723577-8D696F54-0C8F-40D8-A772-E955CA74B9CC

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Various penA mutations togethe ...... ty to cefixime or ceftriaxone.

@en

P2093

Dongeun Yong

http://www.w3.org/2001/XMLSchema#string

Gyung Tae Chung

http://www.w3.org/2001/XMLSchema#string

Hyukmin Lee

http://www.w3.org/2001/XMLSchema#string

Kyungwon Lee

http://www.w3.org/2001/XMLSchema#string

Sang-Guk Lee

http://www.w3.org/2001/XMLSchema#string

Seok Hoon Jeong

http://www.w3.org/2001/XMLSchema#string

Yeong Seon Lee

http://www.w3.org/2001/XMLSchema#string

Yunsop Chong

http://www.w3.org/2001/XMLSchema#string

P2860

Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections

European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.

Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains

Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.

Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.

Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.

Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance.

Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.

Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.

Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea.

P304

669-675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKP505

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41111369

http://www.w3.org/2001/XMLSchema#string

P698

20093260

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria gonorrhoeae

P932

2837549

http://www.w3.org/2001/XMLSchema#string